Oppenheimer analyst Esther Rajavelu raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $42.00 (from $36.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Rocket Pharmaceuticals (RCKT) Prices 3.82M Share Common Offering at $22.25/ShDecember 11, 2019 5:59 AM Rocket Pharmaceuticals (RCKT) Announces Proposed Common Share OfferingDecember 10, 2019 4:02 PM Rocket Pharmaceuticals (RCKT) PT Raised to $33 at Chardan Capital MarketsDecember 9, 2019 8:02 AM